title: [Changes in quality of life in patients with remitted multiple sclerosis during the specific treatment with disease-modifying drugs: a comparative study of populations of Moscow and Novosibirsk].
authors.forename: E V
authors.initials: EV
authors.lastname: Popova
authors.forename: O V
authors.initials: OV
authors.lastname: Riabukhina
authors.forename: O V
authors.initials: OV
authors.lastname: Vorob'eva
authors.forename: N A
authors.initials: NA
authors.lastname: Malkova
authors.forename: A N
authors.initials: AN
authors.lastname: Boĭko
mesh_terms: D000293:Adolescent; D000328:Adult; D003863:Depression / Q000175:diagnosis; D005260:Female; D000068717:Glatiramer Acetate; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009031:Moscow; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy*; D010455:Peptides / Q000627:therapeutic use*; D011788:Quality of Life; D012074:Remission Induction; D012720:Severity of Illness Index; D012800:Siberia; D055815:Young Adult
chemical_list: D010455:Peptides; D000068717:Glatiramer Acetate; D016899:Interferon-beta; D000068556:Interferon beta-1a